871
Views
20
CrossRef citations to date
0
Altmetric
ArticlesCritical Care

Acute topiramate overdose – clinical manifestations

, &
Pages 317-320 | Received 12 Mar 2006, Accepted 10 Nov 2006, Published online: 06 May 2009

References

  • Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, Levy B, Sun X, Fitchet M. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004; 12:1658–1669.
  • Cheseaux M, Monnat M, Zullino DF. Topiramate in benzodiazepine withdrawal. Hum Psychopharmacol 2003; 18:375–377.
  • Glauser TA. Topiramate. Epilepsia 1999; 40(Suppl 5):S71–80.
  • Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004; 75:233–240.
  • Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F. Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004; 37:37–40.
  • Smathers SA, Wilson JG, Nigro MA. Topiramate effectiveness in Prader-Willi syndrome. Pediatr Neurol 2003; 28:130–133.
  • Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) 2004; 40:603–619.
  • Chung AM, Reed MD. Intentional topiramate ingestion in an adolescent female. Ann Pharmacother 2004; 38:1439–1442.
  • Smith AG, Brauer HR, Catalano G, Catalano MC. Topiramate overdose: a case report and literature review. Epilepsy Behav 2001; 2:603–607.
  • Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000; 41(Suppl 1):S35–39.
  • Fakhoury T, Murray L, Seger D, McLean M, Abou-Khalil B. Topiramate overdose: clinical and laboratory features. Epilepsy Behav 2002; 3:185–189.
  • Groeper K, McCann ME. Topiramate and metabolic acidosis: a case series and review of the literature. Paediatr Anaesth 2005; 15:167–170.
  • Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia 2004; 59:830.
  • Galicia SC, Lewis SL, Metman LV. Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction. Clin Neuropharmacol 2005; 28:94–95.
  • Khan A, Faught E, Gilliam F, Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure 1999; 8:235–237.
  • Latour P, Biraben A, Polard E, Bentue-Ferrer D, Beauplet A, Tribut O, Allain H. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?. Hum Psychopharmacol 2004; 19:193–203.
  • Stella F, Caetano D, Cendes F, Guerreiro CA. Acute psychotic disorders induced by topiramate: report of two cases. Arq Neuropsiquiatr 2002; 60:285–287.
  • Langman LJ, Kaliciak HA, Boone SA. Fatal acute topiramate toxicity. J Anal Toxicol 2003; 27:323–324.
  • Lofton AL, Klein-Schwartz W. Evaluation of toxicity of topiramate exposures reported to poison centers. Hum Exp Toxicol 2005; 24:591–595.
  • Sein Anand J, Chodorowski Z, Zbikowska-Bojko M. Acute suicidal intoxication with topiramate. Przegl Lek 2005; 62:519.
  • Traub SJ, Howland MA, Hoffman RS, Nelson LS. Acute topiramate toxicity. J Toxicol Clin Toxicol 2003; 41:987–990.
  • Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC, Jr. Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2004;22:335–404.
  • Watson WA, Litovitz TL, Rodgers GC, Jr., Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21:353–421.
  • McDonald P, McLean M, Thomas R. Topiramate has acute proconvulsant and delayed anticonvulsant effects on cultured central neurons and a mouse seizure model. Neurology 2001; 56:A332–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.